Home / Compare / ANR Clinic vs Texas ibogaine trials (IMPACT consortium)

ANR Clinic vs Texas ibogaine trials (IMPACT consortium)

ANR Clinic and Texas ibogaine trials (IMPACT consortium) side by side: setting, medical team, screening, what is given, length of stay, aftercare, published price and public record. See also the questions to ask.

	ANR Clinic No ibogaine	Texas ibogaine trials (IMPACT consortium) Status unconfirmedClinical trial
Category	ANR (Accelerated Neuro-Regulation). Hospital-based opioid dependence treatment, no ibogaine.	State-funded clinical trial program, not enrolling as of October 2026
Location	Sarasota area, United States	Houston and Galveston, United States
Setting	Hospital ICU. The site describes treatment in a fully accredited hospital ICU with a private hospital room.	Academic hospitals, under an FDA-supervised protocol, once the trial exists.
Medical team	Board-certified anesthesiologists and critical care physicians with ICU nursing (treatment page). The site names Dr. Albert Kabemba (Medical Director) and Dr. Gene Tulman.	University physicians and researchers.
Screening before treatment	A consultation with the medical team and a medical evaluation before admission; the treatment page describes "adjustment of medications when necessary to ensure safe treatment" in the preparation stage. Methadone and buprenorphine (Suboxone, Subutex, Zubsolv) are listed among the drugs treated; the site does not publish a switch-to-short-acting-opioid rule.	Trial eligibility criteria, not yet published.
What is given	No ibogaine. Deep, monitored sedation of about 4 to 5 hours, followed by naltrexone tablets.	To be set by the FDA-approved protocol.
Who it is for	Opioid dependence, including heroin, fentanyl, prescription opioids, methadone and Suboxone; the site also has a kratom dependency page.	Addiction, TBI and other behavioural conditions (the IMPACT consortium: Ibogaine Medicine for PTSD, Addiction and Cognitive Trauma).
Protocol and length of stay	Procedure 4 to 6 hours, hospital stay about 36 hours, then 2 to 3 stabilisation days nearby with follow-ups.	A two-year multicentre trial is planned. As of October 2026 no federally authorised ibogaine trial exists in the United States (ARPA-H).
After the treatment	Naltrexone tablets with the dose set at discharge, as part of a year-long follow-up plan the clinic calls the optimization plan.	Per protocol.
Published price	$21,500, paid as $10,500 at booking and $11,000 the week before the procedure. Includes evaluation, hospital stay, ICU monitoring and follow-up. Not covered by insurance; financing offered.	No fee expected for trial participants.
Licences and accreditations stated	LegitScript certified, NAATP member, BBB accredited A+, ABA badge shown on the site. Treatment takes place in an accredited US hospital.	Texas SB 2308, signed June 2025, appropriated $50 million; HHSC selected UTHealth Houston and UTMB on December 12, 2025.
Founded / history	Over 30 years of development and research behind the method; the site states more than 25,000 patients treated worldwide and a 91% long-term success rate, footnoted as US program outcome data from follow-up on about 1,700 patients treated since 2019, evaluated one year after treatment. US treatment since 2019.	The statute bars disbursement until non-state matching funds arrive. In March 2026 HHSC said no drug-company proposal met the match requirements; state leaders said Texas would fully fund the program. As of October 8, 2026 no executed contract or disbursement had been confirmed.
Rating (as shown on the cited page)	4.71 from 174 reviews (rehab.com, 2026-10-20)	Not shown on the pages we checked
Public record	None found.	None found.
Status	Operating. Site copyright 2026, phone listed.	Status unconfirmed. Not enrolling. Anyone searching for ibogaine in Texas today cannot get it through this program yet.

From each program's website and the sources on its profile, checked 2026-10-20.

Compare other programs